EQUISUL-SDT (Sulfadiazine/Trimethoprim)

EQUISUL-SDT
135ml - bottle
560ml - bottle
900ml - bottle
SKU : 3042135_-RX
Price: $29.95
Veterinarian Prescription (RX) Required
Free Shipping on orders over $75
Low Price Match Guarantee
  • NEW! Oral Liquid Antibacterial for horses -- great for foals!
  • 400mg/ml (333mg sulfadiazine and 67mg of trimethoprim)
  • FDA approved product
  • As an oral sulfa antibiotic, this product works great for treating foals.
  • Similar to the previous Tribissen paste
RX required for this item.
Click here for our full Prescription Policy and Form

Why EQUISUL-SDT?
  • Give at a rate of 2.7 ml or cc per 100 lbs.
  • For treatment of respiratory or other bacterial infections.
  • Don’t have to worry about getting them to eat it like the powder or tablets

Product Features
  • EQUISUL-SDT is proven effective in horses for the treatment of lower respiratory tract infections caused by susceptible strains of Streptococcus equi subsp. zooepidemicus in controlled field trials.
  • EQUISUL-SDT safety was demonstrated in a controlled study in horses at 1X, 3X and 5X the  recommended dose for 30 days.
  • Easy-to-use liquid formulation.
  • Significantly higher bioavailability on a mg-to-mg basis compared to an existing approved paste product, based on a pharmacokinetic crossover study.
  • Low incidence of side effects in our controlled safety studies.

Watch informative video here.

Customer Reviews
(0.00)
# of Ratings: 0
RX required for this item.
Click here for our full Prescription Policy and Form

Why EQUISUL-SDT?
  • Give at a rate of 2.7 ml or cc per 100 lbs.
  • For treatment of respiratory or other bacterial infections.
  • Don’t have to worry about getting them to eat it like the powder or tablets

Product Features
  • EQUISUL-SDT is proven effective in horses for the treatment of lower respiratory tract infections caused by susceptible strains of Streptococcus equi subsp. zooepidemicus in controlled field trials.
  • EQUISUL-SDT safety was demonstrated in a controlled study in horses at 1X, 3X and 5X the  recommended dose for 30 days.
  • Easy-to-use liquid formulation.
  • Significantly higher bioavailability on a mg-to-mg basis compared to an existing approved paste product, based on a pharmacokinetic crossover study.
  • Low incidence of side effects in our controlled safety studies.

Watch informative video here.

Loading...